Thomas Bollenbach, PhD is Chief Technology Officer of ARMI|BioFabUSA. Prior to joining ARMI, Tom served as Vice President of Research and Development at Harvard Apparatus Regenerative Technology, where he led research and preclinical development of stem cell- and biomaterial-based tracheal, bronchial and esophageal implants, and held various positions at Organogenesis Inc., where he led the development of a living, bioengineered skin graft and supported manufacturing sciences. Tom received his B.Sc. in Biochemistry from the University of Waterloo, a Ph.D. in Biochemistry from the University of Notre Dame, and completed postdoctoral research at Cornell University.